Hepatocellular carcinoma - Quiz
A) Cystic and solid B) Encapsulated and diffused C) Nodular and infiltrative D) Fibrous and vascular
A) Yellow B) Green C) Red D) Blue
A) Poorly circumscribed and infiltrative B) Exclusively solitary C) Well circumscribed but not encapsulated D) Completely encapsulated
A) Portal veins B) Pancreatic duct C) Gallbladder D) Bile ducts
A) Two B) Four C) Six D) Five
A) Fibrolamellar B) Small cell C) Papillary D) Squamous
A) Endothelial cells B) Hepatocytes C) Kupffer cells D) Bile duct cells
A) Trabeculae, cords, and nests B) Acini and tubules C) Papillae and follicles D) Sheets and clusters
A) High lipid content B) Poor vascularization C) Rapid cell division D) Bile accumulation
A) Hepatoblastoma-like carcinoma B) Cholangiocarcinoma-like carcinoma C) Sarcomatoid hepatocellular carcinoma D) Lymphoepithelioma-like hepatocellular carcinoma
A) Columnar, glandular, and well-defined B) Uniform, cohesive, and small C) Discohesive, pleomorphic, anaplastic, and giant D) Cuboidal, organized, and encapsulated
A) Calcified B) Fibrotic C) Scant D) Abundant
A) After chemotherapy treatment B) When the tumor is encapsulated C) As a complication of cirrhosis D) In the early stages of development
A) Fatty cell B) Clear cell C) Large cell D) Spindle cell
A) Poorly circumscribed B) Encapsulated C) Well circumscribed D) Solitary nodule
A) X-ray B) MRI C) CT scan D) Ultrasound
A) Two B) Four C) Five D) Three
A) 68% B) 85% C) 90% D) 81%
A) High-intensity pattern B) Iso-intense pattern C) Low-intensity pattern D) Heterogeneous pattern
A) Variable intensity pattern B) High-intensity pattern C) Iso-intense pattern D) Low-intensity pattern
A) HCC-RADS B) LI-RADS C) LIVER-CAT D) LI-SCORE
A) It increases B) It remains the same C) It decreases D) It becomes unreliable
A) Pediatric patients B) Cirrhotic patients C) Patients with fatty liver disease D) Patients with liver trauma
A) 5 B) 6 C) 3 D) 4
A) Only in late stages B) Yes, always C) Only for small lesions D) No, if imaging criteria are met
A) 90% B) 68% C) 85% D) 93%
A) 5% B) 18% C) 50% D) 35%
A) Males B) Elderly individuals C) Children D) Females
A) Hemochromatosis B) Hepatitis B C) Alcohol use D) NASH
A) Hepatitis A B) Hepatitis D C) Hepatitis B D) Hepatitis C
A) 25% B) 80% C) 10% D) 50%
A) Hepatitis C B) Hepatitis A C) Hepatitis B D) Hepatitis E
A) Mercury B) Lead C) Arsenic D) Aflatoxin
A) Hepatitis C B) Hemochromatosis C) Diabetes D) Alcohol use disorder
A) Turner syndrome B) Down syndrome C) Alpha 1-antitrypsin deficiency D) Cystic fibrosis
A) Second B) Third C) Fifth D) First
A) High levels of iron in blood products B) Genetic predisposition to liver tumors C) Side effects of blood clotting medication D) Coincident chronic viral hepatitis infection
A) Beta-catenin activation mutation B) Hepatocyte-only adenoma C) Alpha-fetoprotein dominant D) Fibrolamellar variant
A) Type of carbohydrate consumption B) Circulating insulin concentration C) Physical activity level D) Blood glucose stability
A) High insulin output B) Tight insulin control C) Chronic high blood sugar D) Exclusive use of anabolic steroids
A) Type 1 diabetes B) Chronic kidney disease C) Metabolic syndrome D) Hypertension
A) High glucose consumption or reduced bile flow B) Viral integration or bile salt accumulation C) Increased oxygen uptake or reduced liver size D) Higher replication rate or avoiding apoptosis
A) By blocking the bile salt export pump B) By increasing insulin production in the liver C) By directly converting benign adenomas D) By causing immune cells to attack liver cells
A) Bile salts B) Free radicals C) Insulin-like growth factors D) Steroid hormones
A) 47–60% B) 70–85% C) 10–20% D) 30–40%
A) Reduced bile salt export B) Decreased cell division C) Increased apoptotic rate D) Constitutively active telomerase
A) 60% B) 5% C) 10% D) 30%
A) Wnt B) TERT C) TP53 D) ABCB11
A) AXIN1 B) CTNNB1 C) TP53 D) ABCB11
A) Biopsy B) Physical examination C) Genetic screening D) Blood testing
A) AXIN1 B) ARID1A C) CTNNB1 D) ABCB11
A) Every three months B) Every six months C) Every twelve months D) Every eighteen months
A) 99% B) 41–65% C) 31% D) 80–94%
A) 41–65% B) 99% C) 31% D) 80–94%
A) 60% B) 41% C) 79% D) 97%
A) CT scan B) MRI C) Ultrasound D) PET scan
A) 97% B) 60% C) 31% D) 79%
A) Intravenous contrast in multiple phases B) Oral contrast agents C) Low-dose radiation scanning D) Sedation-free imaging
A) Diagnosis occurs at an advanced stage B) Poor patient compliance C) Lack of available treatment D) Rapid resistance to chemotherapy
A) Liver transaminases B) Alkaline phosphatase C) Des-gamma carboxyprothrombin D) C-reactive protein
A) There is some controversy surrounding whether surveillance reduces mortality B) It is standard of care worldwide C) It is definitively proven to reduce mortality D) It is not recommended under any circumstances |
Created with That Quiz —
where test making and test taking are made easy for math and other subject areas.